![CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia]()
CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemiaDal Bo, M; Bulian, P; Bomben, R; Zucchetto, A; Maria Rossi, F; Pozzo, F; Tissino, E; Benedetti, D; Bittolo, T; Nanni, P; Cattarossi, I; Zaina, E; Chivilò, H; Degan, M; Zaja, F; Pozzato, G; Chiarenza, A; Di Raimondo, F; Del Principe, M I; Del Poeta, G; Rossi, D; Gaidano, G; Gattei, V · Leukemia · 2016